Cytomegalovirus pleuropericarditis after orthotopic liver transplantation

Acta Gastroenterol Belg. 2018 Jul-Sep;81(3):427-429.

Abstract

Cytomegalovirus (CMV) reactivation is a common complication after liver transplantation. In patients with CMV infection, indicated by a positive CMV DNA titer, the presence of any clinical symptom is termed CMV disease. The most common organ affected in CMV disease is the gastrointestinal tract, causing esophagitis, gastritis, enteritis or colitis. CMV infection of the pleura and pericard has been reported in immunocompromised patients, but is rarely seen following liver transplantation.We report a case of a 59-year-old male who developed CMV pleuropericarditis after liver transplantation. Initial ganciclovir treatment did not improve the patient's symptoms and therapy was switched to Foscarnet which ultimately resulted in resolution of infection. However, a few weeks after Foscarnet cessation, the patient again developed bilateral pleural effusion. Ultimate biochemical and clinical response was achieved with IV ganciclovir treatment. The patient was discharged from the hospital with oral Valganciclovir for 3 weeks and has since remained relapse free for >1 year.

Publication types

  • Case Reports

MeSH terms

  • Antiviral Agents / therapeutic use
  • Cytomegalovirus Infections / diagnosis*
  • Cytomegalovirus Infections / etiology
  • Cytomegalovirus Infections / therapy
  • Drainage
  • Ganciclovir / therapeutic use
  • Graft Rejection / prevention & control
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Liver Cirrhosis, Alcoholic / surgery
  • Liver Transplantation*
  • Male
  • Middle Aged
  • Pericardiocentesis
  • Pericarditis / diagnosis*
  • Pericarditis / etiology
  • Pericarditis / therapy
  • Pleurisy / diagnosis*
  • Pleurisy / drug therapy
  • Pleurisy / etiology
  • Thoracentesis
  • Tomography, X-Ray Computed

Substances

  • Antiviral Agents
  • Immunosuppressive Agents
  • Ganciclovir